| Dr Mark M Calder, MD/MPH | |
|
5110 S Yale Ave Ste 320, Tulsa, OK 74135 | |
| (918) 392-4547 | |
| (918) 392-4555 |
| Full Name | Dr Mark M Calder |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 15 Years |
| Location | 5110 S Yale Ave Ste 320, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083841746 | NPI | - | NPPES |
| 2005460610A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0801X | Orthopaedic Surgery - Orthopaedic Trauma | 30496 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Francis Hospital, Inc | Tulsa, OK | Hospital |
| St John Medical Center, Inc | Tulsa, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopedic And Trauma Service Of Oklahoma, Pc | 2163501693 | 9 |
News Archive
Simvastatin might help us control our cholesterol, but when it comes to infection, it's an entirely different story says a new research study published in the Journal of Leukocyte Biology. In the research report, scientists from Italy show that simvastatin delivers a one-two punch to the immune system. First it impairs the ability of specialized immune cells, called macrophages, to kill pathogens. Then, it enhances production of molecules, called cytokines, which trigger and sustain inflammation.
A team of Korean researchers investigated whether "environmental enrichment" can improve the neurobehavioral function of six week-old mice after transplantation of adipose-derived stem cells to treat hypoxic-ischemic brain injury, and found that brain repair (neurogenesis) was aided in some animals through exercise-induced fibroblast growth factor 2 (FGF2), a strong pro-angiogenic factor.
Clinical Foundations, a patient-focused education program dedicated to helping respiratory care professionals stay current on clinical trends, has recently published a new edition titled "Pathogens Associated with the Intensive Care Unit Environment –Considerations for the Respiratory Therapist."
Combination therapy with three generic antiretroviral drugs in a single tablet has been validated for the first time in an open clinical study in a developing country. Follow-up of 60 patients treated in Yaoundé, Cameroon, has demonstrated the excellent efficacy and safety of a generic fixed-dose combination.
› Verified 9 days ago
| Entity Name | Orthopedic & Trauma Service Of Oklahoma, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235316829 PECOS PAC ID: 2163501693 Enrollment ID: O20080508000292 |
News Archive
Simvastatin might help us control our cholesterol, but when it comes to infection, it's an entirely different story says a new research study published in the Journal of Leukocyte Biology. In the research report, scientists from Italy show that simvastatin delivers a one-two punch to the immune system. First it impairs the ability of specialized immune cells, called macrophages, to kill pathogens. Then, it enhances production of molecules, called cytokines, which trigger and sustain inflammation.
A team of Korean researchers investigated whether "environmental enrichment" can improve the neurobehavioral function of six week-old mice after transplantation of adipose-derived stem cells to treat hypoxic-ischemic brain injury, and found that brain repair (neurogenesis) was aided in some animals through exercise-induced fibroblast growth factor 2 (FGF2), a strong pro-angiogenic factor.
Clinical Foundations, a patient-focused education program dedicated to helping respiratory care professionals stay current on clinical trends, has recently published a new edition titled "Pathogens Associated with the Intensive Care Unit Environment –Considerations for the Respiratory Therapist."
Combination therapy with three generic antiretroviral drugs in a single tablet has been validated for the first time in an open clinical study in a developing country. Follow-up of 60 patients treated in Yaoundé, Cameroon, has demonstrated the excellent efficacy and safety of a generic fixed-dose combination.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark M Calder, MD/MPH 5110 S Yale Ave Ste 525, Tulsa, OK 74135-7485 Ph: (918) 392-4547 | Dr Mark M Calder, MD/MPH 5110 S Yale Ave Ste 320, Tulsa, OK 74135 Ph: (918) 392-4547 |
News Archive
Simvastatin might help us control our cholesterol, but when it comes to infection, it's an entirely different story says a new research study published in the Journal of Leukocyte Biology. In the research report, scientists from Italy show that simvastatin delivers a one-two punch to the immune system. First it impairs the ability of specialized immune cells, called macrophages, to kill pathogens. Then, it enhances production of molecules, called cytokines, which trigger and sustain inflammation.
A team of Korean researchers investigated whether "environmental enrichment" can improve the neurobehavioral function of six week-old mice after transplantation of adipose-derived stem cells to treat hypoxic-ischemic brain injury, and found that brain repair (neurogenesis) was aided in some animals through exercise-induced fibroblast growth factor 2 (FGF2), a strong pro-angiogenic factor.
Clinical Foundations, a patient-focused education program dedicated to helping respiratory care professionals stay current on clinical trends, has recently published a new edition titled "Pathogens Associated with the Intensive Care Unit Environment –Considerations for the Respiratory Therapist."
Combination therapy with three generic antiretroviral drugs in a single tablet has been validated for the first time in an open clinical study in a developing country. Follow-up of 60 patients treated in Yaoundé, Cameroon, has demonstrated the excellent efficacy and safety of a generic fixed-dose combination.
› Verified 9 days ago
Dr. Jaclyn Cinda Jones, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1245 S Utica Ave, Tulsa, OK 74104 Phone: 918-579-2590 Fax: 918-579-2599 | |
James F Bischoff, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2448 E 81st St Ste 1200, Tulsa, OK 74137 Phone: 918-900-6432 Fax: 918-392-7057 | |
Rodney L Plaster, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2448 E 81st St Ste 1520, Tulsa, OK 74137 Phone: 918-900-2520 Fax: 918-900-2521 | |
Dr. Wesley M Stotler, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4802 S 109th East Ave, Tulsa, OK 74146 Phone: 918-392-1400 Fax: 918-392-1488 | |
David R. Hicks, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 6585 S Yale Ave Ste 200, Tulsa, OK 74136 Phone: 918-481-2767 Fax: 918-494-9277 | |
Sami Rumi Framjee, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2000 S Wheeling Ave, Suite 1110, Tulsa, OK 74104 Phone: 918-742-7339 Fax: 918-742-2119 | |
Mark Steven Schwartz, D.O. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 6465 S Yale Ave, Suite 420, Tulsa, OK 74136 Phone: 918-502-8810 |